Home
OrbiMed Advisors Israel II, Director: Upstream Bio UPB Buy · Filed 24/10/17
Trade details
- Type
- Insider buy
- Amount
- $11,220,000
- Shares · price
- 660,000 sh · $17.00 a share
- Held after
- 4,554,873 sh
- Stock
- Upstream Bio UPB
- Trade date
- 24/10/15
- Filed
- 24/10/17
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 10 insiders
- Holding change
- +16.9%
Upstream Bio trades, last 26 weeks
What else happened in Upstream Bio around then
Filed or reported within 30 days of the trade day · 24/09/15~24/11/14OrbiMed Advisors Israel II's recent trades
- OrbiMed Advisors Israel II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- OrbiMed Advisors Israel II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- OrbiMed Advisors Israel II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- OrbiMed Advisors Israel II
SellAdicet Bio
SellAdicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
- OrbiMed Advisors Israel II
SellAdicet Bio
SellAdicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
